1. F. Eslami, M. Pourayoubi, F. Sabbaghi, E. Zmeškalová, M. Dušek & S. Baniyaghoob
    Diastereotopic groups in two new single-enantiomer structures (R2)P(O)[NH-(+)CH(C2H5)-(C6H5)] (R = OC6H5 and C6H5)
    Acta Crystallographica Section E 79 (2023) 769-776.
  2. S. Ramesh, E. Zmeškalová, V. Eigner, V. Chelod Paingad, V. Zvoníček, P. Kužel & M. Šoóš
    Structurally Unique Salts of Cyamemazine and Their Pharmaceutical Implications
    Crystal Growth & Design 23 (2023) 168-179.
  3. J. Jirát, J. Rohlíček, J. Kaminský, T. Jirkal, L. Ridvan, E. Zmeškalová, V. Zvoníček, M. Dušek & M. Šoóš
    Formation of ibrutinib solvates: so similar, yet so different
    IUCrJ 10 (2023) 210-219.
  4. F. Mohammadi, H. Mansouri-Torshizi, M. Saeidifar, E. Dehghanian, E. Zmeškalová, M. Dušek & K. Abdi
    Synthesis, characterization, cytotoxicity and DNA/BSA binding of two amino acid palladium(II) complexes derived from alanine and valine
    Nucleosides, Nucleotides and Nucleic Acids 41/1 (2022) 97-122.
  5. Y. Vasilopoulos, J. Heyda, J. Rohlíček, E. Zmeškalová, V. Zvoníček & M. Šoóš
    Impact of Solvent−Drug Interactions on the Desolvation of a Pharmaceutical Solvate
    Journal of Physical Chemistry B 126 (2022) 503-512.
  6. A. Chatziadi, E. Zmeškalová, M. Kohout, L. Ridvan & M. Šoóš
    Exploring the polymorphism of sofosbuvir via mechanochemistry: effect of milling jar geometry and material
    CrystEngComm 24 (2022) 2107-2117.
  7. A. Chatziadi, E. Zmeškalová, J. Jirat, J. Rohlíček & M. Šoóš
    Characterization and Insights into the Formation of New Multicomponent Solid Forms of Sofosbuvir
    Crystal Growth & Design 22 (2022) 3395-3404.
  8. F. Eslami, M. Pourayoubi, F. Sabbaghi, M. Dušek, E. Zmeškalová
    Database Survey of Single-and-Half Phosphorus–Oxygen Bonds in Salts with the C2PO2 Segment: Crystal Structure of [NH2C5H4NH][(C6H5)2P(O)(O)].2H2O
    Crystallography Reports 67(2) (2022) 218-223.
  9. E. Hriňová, E. Zmeškalová, I. Čerňa, J. Královičová, P. Kozlík, T. Křížek, J. Roušarová, P. Ryšánek, M. Šíma, O. Slanař & M. Šoóš
    Explaining dissolution properties of rivaroxaban cocrystals
    International Journal of Pharmaceutics 622 (2022) 121854(1)-121854(10).
  10. J. Jirát, M. Babor, L. Ridvan, E. Zmeškalová, M. Dušek & M. Šoóš
    Structure–property relations of a unique and systematic dataset of 19 isostructural multicomponent apremilast forms
    IUCrJ 9 (2022) 508-515.
  11. E. Zmeškalová, M. Václavík, J. Jirát, M. Poupon, L. Ridvan, M. Babor & M. Šoóš
    Obeticholic Acid Forms Two Series of Isostructural Nonstoichiometric Channel Solvates
    Crystal Growth & Design 22 (2022) 5589-5597.
  12. S. Hosseinpoor, M. Pourayoubi, E. Zmeškalová
    A comparative conformational study of (C6H5O)2P(O)(NHC(S)NHCH2C6H5) and analogous X-ray structures: energy calculations (solid-state/gas phase)
    Phosphorus, Sulfur, and Silicon and the Related Elements 197(7) (2022) 747-757.
  13. M. Hakimi, B. Tarani, Z. Mardani, H. Hassani, E. Zmeškalová
    Synthesis and characterization of a manganese(II) complex containing N(sp2)4-donor Schiff base ligand and interaction toward biomacromolecules
    Inorganic and Nano-Metal Chemistry - (2021) 1-10.
  14. E. Zmeškalová, J. Rohlíček, A. Chatziadi, V. Zvoníček, J. Jirát, J. Čejka, L. Ridvan & M. Šóoš
    Low-temperature polymorphs of lacosamide
    Journal of Crystal Growth 562 (2021) 126085(1)-126085(7).
  15. N.L. Zakaria, M. Pourayoubi, M.E. Toularoud, E. Zmeškalová
    Structural differences/similarities of diastereotopic groups in three new chiral phosphoramides
    Acta Crystallographica Section C 77 (2021) 186-196.
  16. J. Jirát, V. Zvoníček, M. Babor, L. Ridvan, E. Zmeškalová, M. Dušek, M. Šoóš
    Formation of the First Non-Isostructural Cocrystal of Apremilast Explained
    Crystal Growth & Design 20 (2020) 5785-5795.
  17. J. Rohlíček. V. Zvoníček, E. Zmeškalová, M. Šoóš
    Testing the flow-through capillary for the study of re-solvation processes in pharmaceutical compounds
    Powder Diffraction 35 (2020) 160-165.
  18. A. Chatziadi, E. Zmeškalová, J. Rohlíček, M. Dušek, L. Ridvan, M. Šoóš
    Mechanochemically Induced Polymorphic Transformations of Sofosbuvir
    Crystal Growth & Design 20 (2020) 139-147.
  19. Z. Asadi, L. Zarei, M. Golchin, E. Zmeškalová, V. Eigner, Z. Amirghofran
    A novel Cu(II) distorted cubane complex containing Cu4O4 core as the first tetranuclear catalyst for temperature dependent oxidation of 3,5-di-tert-butyl catechol and in interaction with DNA & protein (BSA)
    Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 227 (2020) 117593(1)-117593(15).
  20. S.J. Sardroud, S.A. Hosseini-Yazdi, M. Mahdavi, M. Poupon, E. Zmeškalová
    Synthesis, characterization and in vitro evaluation of anticancer activity of a new water-soluble thiosemicarbazone ligand and its complexes
    Polyhedron 175 (2020) 114218(1)-114218(10).
  21. U.B. Rao Khandavilli, L. Keshavarz, E. Zmeškalová, R.R.E. Steendam, P.J. Frawley
    Organic Salts of Pharmaceutical Impurity p-Aminophenol
    Molecules 25 (2020) 1910(1)-1910(10).
  22. E. Zmeškalová, A. Harchani, M.M. Ftini, M. Dušek, A. Haddad
    Crystal structure of a new polyoxometalate (POM) compound with a high level of crystallographic disorder
    Acta Crystallographica Section C 76 (2020) 164-169.
  23. E. Zmeškalová
    CrystalCMP: automatic comparison of molecular structures
    Journal of Applied Crystallography 53 (2020) 841-847.
  24. V. Štejfa, T. Mahnel, E. Zmeškalová, J. Rohlíček, V. Eigner, B. Schröder, K. Růžička & M. Fulem
    A combined thermodynamic and crystallographic study of 1,3-diisopropylnaphthalene
    Journal of Chemical Thermodynamics 150 (2020) 106193(1)-106193(10).
  25. V. Štejfa, A. Bazyleva, M. Fulem, J. Rohlíček, E. Zmeškalová, K. Růžička, A.V. Blokhin
    Polymorphism and thermophysical properties of l- and dl-menthol
    Journal of Chemical Thermodynamics 131 (2019) 524-543.
  26. V. Zvoníček, E. Zmeškalová, M. Dušek, P.Žvátora, M. Šoóš
    Ibrutinib Polymorphs: Crystallographic Study
    Crystal Growth & Design 18 (2018) 1315-1326.
  27. E. Zmeškalová, I. Čerňa, R. Vlasáková, V. Zvoníček, M. Tkadlecová, M. Dušek
    Spirocyclic character of ixazomib citrate revealed by comprehensive XRD, NMR and DFT study
    Journal of Molecular Structure 1148 (2017) 22-27.
  28. V. Zvoníček, E. Zmeškalová, M. Dušek, M. Babor, P. Žvátora, M. Šoóš
    First Crystal Structures of Pharmaceutical Ibrutinib: Systematic Solvate Screening and Characterization
    Crystal Growth & Design 17 (2017) 3116-3127.
  29. E. Tieger, V. Kiss, G. Pokol, Z. Finta, M. Dušek, J. Rohlíček, E. Zmeškalová, P. Brázda
    Studies on the crystal structure and arrangement of water in sitagliptin L-tartrate hydrates
    CrystEngComm 18 (2016) 3819-3831.
  30. E. Zmeškalová, M. Hušák, L. Ridvan, M. Tkadlecová, J. Havlíček, M. Dušek
    Iodine salts of the pharmaceutical compound agomelatine: the effect of the symmetric H-bond on amide protonation
    CrystEngComm 18 (2016) 4518-4529.
  31. J. Rohlíček, E. Zmeškalová, M. Babor, J. Čejka
    CrystalCMP: an easy-to-use tool for fast comparison of molecular packing
    Journal of Applied Crystallography 49 (2016) 2172-2183.
  32. E. Tieger, V. Kiss, G. Pokol, Z. Finta, J. Rohlíček, E. Zmeškalová, M. Dušek
    Rationalization of the formation and stability of bosutinib solvated forms
    CrystEngComm 18 (2016) 9260-9274.
  33. J. Holaň, E. Zmeškalová, L. Heraud, D. Baltes, J. Rohlíček, O. Dammer, L. Ridvan, F. Štěpánek
    Polymorphic Crystallization and Structural Aspects of Agomelatine Metastable Form X Prepared by Combined Antisolvent/Cooling Process
    Organic Process Research & Development 20 (2016) 33-43.
  34. V. Sládková, T. Skalická, E. Zmeškalová, J. Čejka, V. Eigner, B. Kratochvíl
    Systematic solvate screening of trospium chloride: discovering hydrates of a long-established pharmaceutical
    CrystEngComm 17 (2015) 4712-4721.
  35. E. Zmeškalová, J. Čejka, M. Hušák, V. Eigner, J. Rohlíček, A. Šturc, B. Kratochvíl
    Trospium Chloride: Unusual Example of Polymorphism Based on Structure Disorder
    Crystal Growth & Design 13 (2013) 5193-5203.